Leukoaraiosis may affect life expectancy. Leukoaraiosis, also known as Behçet’s syndrome, is a chronic systemic vasculitis, which often manifests itself clinically as oral ulcers, genital ulcers, ophthalmia, etc. However, the disease can involve the whole body system, such as the nervous system, the digestive system, and the cardiovascular system. Although most patients have a good prognosis, some patients with Behçet’s syndrome involve multiple organ systems and when the condition is severe, life expectancy may be affected. Therefore, after the diagnosis of Behçet’s syndrome, active treatment should be carried out. Thalidomide tablets can be used to inhibit angiogenesis as prescribed by the doctor, and at the same time, non-steroidal anti-inflammatory drugs, such as diclofenac sodium delayed-release tablets, glucocorticosteroids, such as prednisone and other symptomatic, and methotrexate, such as suppression of immune therapy, as prescribed by the doctor. All of the above medications should be used under the guidance of a doctor, avoid self-medication, it is recommended that patients with Behçet’s syndrome go to the rheumatology and immunology department as soon as possible, under the guidance of the doctor for standardized treatment.